Organogenesis Holdings Inc.
ORGO
$4.88
$0.214.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 27.10% | 6.12% | 11.01% | 2.17% | -13.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.10% | 6.12% | 11.01% | 2.17% | -13.73% |
| Cost of Revenue | 11.82% | 3.90% | 10.95% | 7.85% | 2.43% |
| Gross Profit | 33.00% | 6.82% | 11.03% | 0.30% | -18.69% |
| SG&A Expenses | 24.20% | 11.96% | 8.66% | 0.55% | -20.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.61% | 8.52% | 12.65% | 3.73% | -12.27% |
| Operating Income | 1,474.58% | -23.36% | -7.38% | -84.04% | -75.67% |
| Income Before Tax | 670.88% | -23.75% | -258.41% | 6.14% | -120.52% |
| Income Tax Expenses | 310.10% | -245.59% | -35.21% | -35.28% | -196.85% |
| Earnings from Continuing Operations | 1,450.88% | 289.36% | -420.60% | 29.27% | -107.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,450.88% | 289.36% | -420.60% | 29.27% | -107.59% |
| EBIT | 1,474.58% | -23.36% | -7.38% | -84.04% | -75.67% |
| EBITDA | 201.75% | -10.67% | 0.25% | -93.39% | -10.03% |
| EPS Basic | 1,153.49% | 285.89% | -417.53% | 29.65% | -107.52% |
| Normalized Basic EPS | 8,133.33% | -25.27% | -9.74% | -58.46% | -95.35% |
| EPS Diluted | 1,032.56% | 350.00% | -425.00% | 11.50% | -107.52% |
| Normalized Diluted EPS | 7,983.33% | -24.86% | -8.47% | -58.46% | -95.31% |
| Average Basic Shares Outstanding | -0.95% | 0.96% | 0.97% | 0.59% | 0.00% |
| Average Diluted Shares Outstanding | 0.23% | 0.38% | -0.37% | 0.59% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |